TRADE AGENDA AND ACCESS TO MEDICINES
25 October 2010 - Policy brief on ACTA and Access to Medicines
13 November 2009 - Joint declaration from Oxfam, Health Action International and Médecins Sans Frontières in Spanish
1 December 2009 - HAI Europe response to the European Commission’s Global Health consultation
11 Janaury 2010 - Open Letter to Commissioner de Gucht on Joint Declaration
11 January 2010 - Joint Declaration Trading Away Access...
19 February 2010 - Press release prioritise and protect Access to medicines in Central America
22 March 2010 - HAI Europe response to the DG Trade Consultation on ACTA
26 April 2010 - Compulsory licenses in Ecuador
27 April 2010 - EU-India FTA poses a serious threat
29 July 2010 - Joint Open letter on ACTA to DG Trade Commissioner de Gucht from HAI Europe, Oxfam, Knowledge Ecology International, Public Citizen and Vrijschrift
29 July 2010: Joint civil society letter on ACTA and Access to Medicines to Trade Commissioner de Gucht.
Intellectual property enforcement initiatives threaten consumer rights and public health
12 June 2009 - The TransAtlantic Consumer Dialogue (TACD), Health Action International (HAI) and Knowledge Ecology International (KEI) hosted a public meeting on the issue of intellectual property rights enforcement in Brussels on Wednesday, June 10th. Click here for joint press release
HAI Members'Comment on Anti-Counterfeiting Trade Agreement
3 July 2009 - Health Action International (HAI) members in Canada have contributed to the public debate on ACTA by submitting comments to the Canadian government’s Consultation & Liaisons Division. Please click here to read the submission and the TransAtlantic Consumer Dialogue (TACD) Resolution on the enforcement of copyright, trademarks, patents and other intellectual property rights.
Joint Oxfam International & HAI Europe briefing paper
20 October 2009 - Trading Away Access to Medicines. How the European Union's trade agenda has taken a wrong turn. Full Report in French and Full Report in Spanish
Latin-American – Global Alliance for Access to Medicines
24 April 2010 – Declaration of Quito from the IV Meeting of LAC – Global Alliance for Access to Medicines. Also in Spanish
EU-CAN Alliance on Access to Medicines
HAI Europe and HAI Latin America have formed an alliance between European and Latin American civil society to monitor and lobby negotiations on Association Agreements between the EU and the countries of the Andean region. Rigid Intellectual Property Rights provisions demanded by the EU are likely to have a negative effect on Access to Essential Medicines.
HAI Europe coordinates civil society efforts in Europe and raises awareness at the European Parliament, the Commission and the Council about the potentially harmful impact of the Association Agreements on public health in the Andean countries.
HAI Latin America will bring together civil society organisations in the region, lobby their respective national governments and provide the evidence base to support the HAI Europe advocacy campaign.
2 December 2008 Policy Brief - The EU-CAN Association Agreement, Access to Medicines in jeopardy!
February 2009 Factsheet - EU-CAN Association Agreements Negotiations – This factsheet was developed in cooperation with Evert Vermeer Stichting in the context of their European Union Coherence programme
9 February 2009 Open letter - EU-CAN Alliance to the European Commission and Members of the European Parliament on the negotiations round 9-13 February 2009 in Bogota. Plus, an Annex on the public health concerns with the intellectual propoerty chapter in the trade agreements.
17 February 2009 - Expert Meeting at the European Parliament: In cooperation with the EU Coherence Programme (www.eucoherence.org), HAI Europe hosted an expert meeting on the bilateral negotiations on trade agreements between the European Union and the Andean community (CAN) countries: Bolivia, Colombia, Ecuador, Peru. Please see the final programme, speaker presentation summaries , concept note , press release and event memo for more information
March 2009 Publication - Health Protection in the European and Andean Association Agreement. by Xavier Seuba Hernandez also available in Spanish, Executive Summary and Conclusions
24 March 2009 - Highlights from the Peru and Colombia Impact Studies: EU Intellectual Property proposals presented during the negotiation rounds in Lima. See press release
23 April 2009 Open letter - EU-CAN Alliance to the European Council on the negotiations round 4-9 May 2009 in Brussels. Plus, Annex 1 on the public health concerns with the intellectual property chapter in the trade agreements and Annex 2 .
1 May 2009 - Summary of Preliminary Results Peru Colombia Impact Studies
1 May 2009 Policy Brief - Protecting Access to Medicines in EU Trade Agreements: The Andean Region
6 May 2009 – Press release - EU's Intellectual Property agenda could impair access to medicines in the Andean region
16 June 2009 Press release - EU Commission pushes its trade agenda on Andean nations despite public health consequences
20 July 2009 - Press release - EU negotiators are trading away Access to Medicines in Andean countries- Following the round of trade negotiations between the European Union and Peru and Colombia in Lima, Peru, the CAN-EU Alliance of European and Andean civil society organisations is calling on the EU to abandon all TRIPS plus demands in order to protect access to medicines for the Andean populations.
11 November 2009 - Final Report: Impact of the EU-Andean Trade Agreements on Access to Medicines in Peru. Click here for the full report in Spanish.
16 December 2009 Presentation - Impact of EU Trade Agreements on Access to Medicines
29 March 2010 Impact of the EU-Andean Trade Agreement on Access to Medicines in Colombia
DUTCH SEIZURES OF GENERIC MEDICINES IN TRANSIT
The case of the losartan seizure, which became public in January 2009,
was a clear demonstration of European enforcement of intellectual
property (IP) rights trumping access to medicines. HAI immediately
responded to this news with a press release, highlighting the
inconsistency between the EU’s uncompromising IP enforcement agenda
and commitments made by EU Member States, including the Netherlands,
to promote and protect public health in developing countries.
This was followed by a joint letter with the Trans Atlantic Consumer Dialogue and a joint letter from HAI and Oxfam Novib to the Dutch Ministries Finance, Economic Affairs, Foreign Affairs, and Health, which called on the authorities to assess and determine conclusively whether the present EU regulations and practices on border measures are consistent with policies for facilitating universal access to medicines.
HAI was also part the group of NGOs that sent letters to the WHO and
WTO, demanding that the WHO “immediately undertake an assessment of
the risks to public health programs presented by such seizures” and
that the WTO examine whether EU “customs rules and provisions in trade
agreements present risks to goods in transit, and undermine the
commitments made in 2001 in the Doha Declaration on TRIPS and Public
Health concerning access to medicines.”
HAI then issued a statement following, WTO Director-General, Pascal
Lamy’s response to the NGO letter.
The news at the end of February about the seizure of a UNITAID/Clinton
Foundation shipment of ARV medicines brought home the importance of
tackling these interventions in the legitimate trade of generic
medicines. HAI issued a joint press release with Oxfam International
and Knowledge Ecology International to condemn this unacceptable
seizure of HIV/AIDS medicine that threatened the treatment of HIV
Following the recent release of the UNITAID shipment, HAI issued a statement on 20 March 2009 welcoming the release of these life-saving medicines but urging the authorities to refrain from seizing generics by applying overambitious border measures and allowing IP enforcement measures to distort or corrupt the free movement of legitimate medicines in transit.
At the beginning of April 2009, HAI filed an official request with the Dutch government, under the Wet Openbaar Bestuur (the Dutch-equivalent of a Freedom of Information Act), to release all documents related to the recent seizures of generic medicines in transit (click here for the statement). On 7 May 2009, HAI received the Official Response to Freedom of Information request, which is also available in Dutch.
On 5 May 2009, a shipment of the antibiotic, Amoxicillin, manufactured in India and destined for the Republic of Vanuatu in the Pacific, was seized by customs officials while in transit through Frankfurt, Germany. Amoxicillin is an essential medicine used to treat a wide range of bacterial infections. Please see the joint press release from Health Action International (HAI), Oxfam International, BUKO-pharma, Medico International and Third World Network.
11 August 2009 – HAI Europe Statement on the latest developments on seizures of generic medicines in-transit